Determinants of BMI in patients with COPD

Respirology

Volumn 9, Issue 1, 2004, Pages 70-75

  Karadag, Fisun ^a   Karul, Aslihan B ^a   Cildag, Orhan ^a   Altun, Cagatay ^a   Gurgey, Ozgur ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Body mass index; Chronic obstructive pulmonary disease; Cytokines; Malonyldialdehyde; Tumour necrosis factor

Indexed keywords

MALONALDEHYDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING;

AGED; BODY MASS INDEX; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 2442528455     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2003.00533.x     Document Type: Article

References (40)

1. Barnes PJ. Chronic obstructive pulmonary disease. N. Engl. J. Med. 2000; 343: 269-80.
2. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur. Respir. J. 2001; 34 (Suppl.): 50s-59s.
3. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the Lung Health Study. Am. J. Respir. Crit. Care Med. 2000; 161: 381-90.
4. He B, Zhao M, Qi G. Activation of transcription factors and induction of cytokines from macrophages in chronic obstructive pulmonary disease. Zhonghua Yi Xue Za Zhi 2001; 81: 1360-4.
5. Wang S, Xu F, Chen Y. Detection and significance of interleukin-8, 6, TNF-α in sputa from patients with chronic obstructive pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi 2000; 23: 465-7.
6. + T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157: 822-6.
7. Vernooy JH, Kucukaycan M, Jacobs JA et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am. J. Respir. Crit. Care Med. 2002; 166: 1218-24.
8. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest 2002; 121 (Suppl.): 127s-130s.
9. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 819-24.
10. Eid AA, Ionescu AA, Nixon LS et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001; 164: 1414-18.
11. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1994; 150: 1453-5.
12. de Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM. Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients. Am. J. Respir. Crit. Care Med. 1996; 153: 633-7.
13. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157: 1791-7.
14. Tracey KJ, Cerami A. Metabolic responses to cachectin/TNF. A brief review. Ann. NY. Acad. Sci. 1990; 587: 325-31.
15. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 1994; 45: 491-503.
16. Takabatake N, Nakamura H, Abe S et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-α system in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000; 161: 1179-84.
17. Ghezzi P, Dinarello CA, Bianchi M, Rosandich ME, Repine JE, White CW. Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine 1991; 3: 189-94.
18. Scannell G, Waxman K, Kaml GJ et al. Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. J. Surg. Res. 1993; 54: 281-5.
19. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1995; 152: 77-120.
20. WHO Expert Committee. Physical Status: the Use and Interpritation of Anthropometry. WHO Technical Report Series No: 854. WHO, Geneva.
21. American Thoracic Society. Standardization of spirometry, 1994 update. Am. J. Respir. Crit. Care Med. 1995; 152: 1107-36.
22. Siafakas NM, Vermeire P, Pride NB et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur. Respir. J. 1995; 8: 1398-420.
23. Aukrust P, Müller F, Lien E et al. Tumor necrosis factor (TNF) system levels in human immunodeficiency virusinfected patients during highly active antiretroviral therapy. Persistent TNF activation is associated with virologic and immunologic treatment failure. J. Infect. Dis. 1999; 179: 74-82.
24. Gerlag DM, Ransone L, Tak PP et al. The effect of a T cell-specific NF-kappaB inhibitor on in vitro cytokine production and collagen-induced arthritis. J. Immunol. 2000; 165: 1652-8.
25. 2. J. Immunol. 2000; 164: 5120-4.
26. MacNee W, Rahman I. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 160 (Suppl.): S58-S65.
27. Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am. J. Obstet. Gynecol. 1979; 135: 372-6.
28. Van der Poll T, Romijn JA, Endert E, Borm JJ, Buller HR, Sauerwein HP. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am. J. Physiol. 1991; 261: E457-65.
29. Churg A, Dai J, Tai H, Xie C, Wright JL. Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am. J. Respir. Crit. Care Med. 2002; 166: 849-54.
30. Pessina GP, Paulesu L, Corradeschi F et al. Production of tumor necrosis factor-alpha by rat alveolar macrophages collected after acute cigarette smoking. Arch. Immunol. Ther. Exp. (Warsz). 1993; 41: 343-8.
31. Turato G, Di Stefano A, Maestrelli P et al. Effect of smoking cessation on airway inflammation in chronic bronchitis. Am. J. Respir. Crit. Care Med. 1995; 152: 1262-7.
32. Klesges RC, Klesges LM, Meyers AW. Relationship of smoking status, energy balance, and body weight: analysis of the Second National Health and Nutrition Examination Survey. J. Consult. Clin. Psychol. 1991; 59: 899-905.
33. Di Stefano A, Capelli A, Lusuardi M et al. Severity of air-flow limitation is associated with severity of airway inflammation in smokers. Am. J. Respir. Crit. Care Med. 1998; 158: 1277-85.
34. Larsen GL, Webster RO, Worthen GS, Gumbay RS, Henson PM. Additive effect of intravascular complement activation and brief episodes of hypoxia in producing increased permeability in the rabbit lung. J. Clin. Invest. 1985; 75: 902-10.
35. Aaron SD, Angel JB, Lunau M et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001; 163: 349-55.
36. Malo O, Sauleda J, Busquets X, Miralles C, Agusti AG, Noguera A. Systemic inflammation during exacerbations of chronic obstructive pulmonary disease. Arch. Bronconeumol. 2002; 38: 172-6.
37. Karakurum M, Shreeniwas R, Chen J et al. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J. Clin. Invest. 1994; 93: 1564-70.
38. Pedersen BK, Kappel M, Klokker M, Nielsen HB, Secher NH. The immune system during exposure to extreme physiologic conditions. Int. J. Sports Med. 1994; 15: S116-21.
39. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines, and disease. Annu. Rev. Cell Biol. 1993; 9: 317-43.
40. Takabatake N, Nakamura H, Abe S et al. Circulating leptin in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 159: 1215-19.